This Event has Passed
- Virtual
New Opportunities for Human Stem Cells in Research and Clinical Applications
Learn more about STAT Brand Studio and partner with us for your next event!
Where
Virtual
When
{{getUserDateTimezone("1707336000").singleDate}}
{{getUserDateTimezone("1707336000").time}} - {{getUserDateTimezone("1707337800").time}} {{getClientTimezoneName()}}
About
iPSCs (induced pluripotent stem cells), an inexhaustible source of functional human cells, have enormous potential for biomedical research and health care. They are being used to study genetic disease, new drug development, and treatment of a broad range of disorders — diabetes, cancer, neurological illnesses, and more. This forum explores uses of iPSCs for new strategies in preclinical and clinical applications.
Moderator
Jesse McQuarters, Branded Content Editor at STAT
Speaker
Ilyas Singeç, M.D., Ph.D. Chief Scientific Officer, FUJIFILM Cellular Dynamics, Inc.
Ilyas was the inaugural director of the Stem Cell Translation Laboratory at NCATS/NIH, where he led the development of innovative technologies to help translate iPSC technology into clinical applications and drug discovery.
Upcoming Events
The last 10 years have seen incredibly significant medical breakthroughs thanks to targeted and precision medicine. At the same time, the la…
In the last year, obesity drugs have dominated headlines and taken center stage, representing an emerging market that has potential to trans…
On April 25th, join STAT for a conversation with past all-star Wunderkinds to see where they are now and hear their most inspiring and innov…